© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
748024 |
| Productname | 6-Bromo-2-Methyl-4-Azabenzimidazole |
| Casnumber | 200882-97-1 |
| Molecularformula | C8H6BrN3 |
| Molecularweight | 224.06 |
| Appearance | White to off-white solid |
| Solubility | Soluble in DMSO, slightly soluble in water |
| Purity | Typically >98% |
| Storagetemperature | Store at 2-8°C |
| Smiles | CC1=NC2=C(N1)C=C(C=C2)Br |
| Inchi | InChI=1S/C8H6BrN3/c1-5-11-8-6(2-3-7(9)4-10-8)12-5/h2-4H,1H3 |
As an accredited 6-Bromo-2-Methyl-4-Azabenzimidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-2-Methyl-4-Azabenzimidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years of collaborating in synthetic labs have taught me that success in drug development and advanced chemical synthesis depends on each step—from careful planning to the quality of every reagent. That’s where 6-Bromo-2-Methyl-4-Azabenzimidazole shows its worth. Coming from a generation of chemists who appreciate real reliability, I see this compound standing out as a vital intermediate for teams shaping the future of medicinal and materials science research. With a molecular formula of C8H6BrN3, it boasts a unique scaffold, allowing researchers to access novel structures with fewer synthetic bottlenecks.
Few compounds combine innovation and versatility quite like 6-Bromo-2-Methyl-4-Azabenzimidazole. The 6-bromo substitution brings a precise reactive handle to the benzimidazole core, a scaffold already well known among medicinal chemists. Adding a methyl group at position 2 unlocks more possibilities for fine-tuning electronic and steric effects, which can help drive selectivity or biological activity in exploratory leads. I’ve seen firsthand how this compound slots into existing synthetic pathways, making it a useful choice for both routine analog building and the design of novel molecules.
What matters most to researchers juggling tight deadlines and grant applications isn’t just technical jargon—it’s how a compound behaves at the bench. Here, the solid form and stability of 6-Bromo-2-Methyl-4-Azabenzimidazole become a major advantage. In my experience, batches arrive pure, typically as off-white to pale yellow crystals, indicative of good synthesis and purification. Handling doesn’t call for exotic protocols; airtight bottles shield it from moisture, and refrigeration preserves sample longevity. This reliability reduces stress for small biotech teams and academic labs, where downtime hits hard.
Research pipelines thrive on creative problem solving. Across the labs I’ve known—university, start-up, and corporate R&D—6-Bromo-2-Methyl-4-Azabenzimidazole opens pathways to heterocyclic compounds. The value comes especially during coupling reactions, where the bromine serves as a launching pad for Suzuki, Buchwald-Hartwig, and other cross-coupling methods. I remember a postdoc colleague transforming this intermediate into a series of kinase inhibitors, leveraging that bromine site for easy diversification. This flexibility lets chemists push beyond well-trodden routes and tackle libraries with greater diversity.
Medicinal chemistry has an unending appetite for new scaffolds. As teams push toward harder targets—those elusive protein-binding sites or unique enzyme inhibitors—functionalized imidazoles such as 6-Bromo-2-Methyl-4-Azabenzimidazole deliver structural features rarely found in natural products. Its methyl group can improve pharmacokinetic properties and help tune metabolic stability. I’ve watched project teams use this compound as a starting point, then branch out into a full suite of analogs, comparing biological activity across a spectrum of animal models and cell-based assays. Results from these programs feed into publications and pipeline advancement, fueling real progress.
Plenty of benzimidazole derivatives flood the market, but very few offer both a bromo group at the 6-position and a methyl at the 2-position. Often, standard 2-methyl or mono-bromo analogs lack this dual functionality, forcing researchers into extra synthetic steps. In my years of teaching advanced organic synthesis, I saw students appreciate how this compound’s substitution pattern brings down the reaction count and boosts overall yield. The 6-bromo allows for rapid cross-coupling, which is a game-changer when optimizing reaction cascades or branching into parallel chemistry efforts.
Modern science expects speed, but chasing shortcuts can lead to unreliable data or inconsistent results. Specialty intermediates like 6-Bromo-2-Methyl-4-Azabenzimidazole tick off both quality and convenience. Bringing down procedural complexity means researchers can devote more energy to experimental design and less to correcting failed reactions. As someone who mentors graduate students, I’ve seen frustration turn to enthusiasm simply because a reaction works on the first try. Small differences in building blocks ripple through projects, raising the bar for reproducibility and trust in final compounds.
Escalating competition in pharmaceuticals and fine chemicals puts ever more pressure on sourcing unique, versatile intermediates. I’ve watched senior chemists wrestle with subpar alternatives, and the heartbreak of losing weeks to unreliable compounds is real. 6-Bromo-2-Methyl-4-Azabenzimidazole’s robust track record and predictable performance give it an edge over generic benzimidazoles or derivatives lacking the right substitution pattern. For research teams with tight project milestones, the difference between success and delay often comes down to finding an intermediate that actually delivers on its promise.
Back as a research assistant, I learned the hard way that not all reagents are created equal. Analytical certificates and batch-level data aren’t just paperwork—they’re the backbone of reliable science. With 6-Bromo-2-Methyl-4-Azabenzimidazole, suppliers typically provide NMR, HPLC, and mass spectrometric profiles to back purity and identity. Anyone who’s spent time troubleshooting failed syntheses knows the cost of cutting corners, so these checks matter. Consistency from batch to batch let researchers focus on innovation, not quality assurance nightmares.
Attention to environmental impact is growing in every sector of chemistry. I’ve worked on process teams where waste and sustainability prompted a deep look at every reagent’s life cycle. By allowing efficient coupling and minimizing protecting group manipulation, 6-Bromo-2-Methyl-4-Azabenzimidazole enables chemists to design shorter, less wasteful routes. Cut one unnecessary purification, and you save solvents, time, and energy. Greater atom economy builds not just better molecules, but cleaner ones, letting researchers reach sustainability goals without compromising discovery.
I’ve seen well-designed projects falter on issues that few anticipate—solubility hiccups, side reactions, or the need for better reactivity. With this compound, most reaction conditions remain straightforward, but a few solvent choices or bases can make a big difference in outcome. Colleagues in hit-to-lead teams keep detailed notebooks on optimal conditions, documenting tweaks that maximize yield or minimize impurities. The beauty of 6-Bromo-2-Methyl-4-Azabenzimidazole lies in its flexibility—it fits a wide spread of methods, from palladium coupling to nucleophilic substitution. The learning curve is gentle, especially for labs familiar with benzimidazole chemistry.
Patent filings in the pharmaceutical sector reflect a race to novel scaffolds and proprietary chemistry. The rare substitution pattern of 6-Bromo-2-Methyl-4-Azabenzimidazole gives a head start for teams working on patentable drug candidates or agrochemical leads. Over the years, I’ve seen organizations pour resources into finding white space in saturated chemical areas; sometimes, a single new intermediate opens the road to an untapped mechanism or patent family. As research teams push boundaries, compounds like this become vital chess pieces in the game of innovation.
Supply chain glitches have dogged scientific research more sharply in recent years. I’ve fielded questions from academic collaborators dealing with delays, missing shipments, or poorly documented batches. Trustworthy supply of 6-Bromo-2-Methyl-4-Azabenzimidazole helps insulate projects from such hurdles. Leading chemical suppliers know researchers can’t afford to chase down batches or compromise on documentation, so demand for this compound is consistently strong across continents, from Asia to North America. The pattern shows research is truly global—bench work in one city often feeds seamless into a next-stage project half a world away.
I’ve sat across the table from junior scientists unsure where to begin with a fresh intermediate. My advice always leaves theory behind and gets straight to action—start by mapping reaction pathways that take advantage of the compound’s bromine reactivity. Peer-reviewed literature and patent filings offer starting points, but careful planning and a dash of creativity make all the difference. Many teams find success by running parallel reactions, collecting kinetics data, and testing a range of coupling partners. Lessons learned here build confidence, turning the unfamiliar into the backbone of project milestones.
Management tracks project timelines in months, but scientists fight each battle by the day. In my own postdoctoral work, slowdowns triggered by reagent shortages stung most, since they stacked up downstream delays. The ready availability and consistent quality of 6-Bromo-2-Methyl-4-Azabenzimidazole prevent these headaches. Projects don’t stall at the intermediate stage, giving principal investigators and project managers greater confidence that deadlines will hold. In competitive funding cycles, hitting milestones matters—not just for progress, but for reputations and future opportunity.
Not every lab boasts a high-throughput robotic platform or a sprawling team. Graduate students and small biotech start-ups often work on shoestring budgets, making every purchase count. In such environments, dependable compounds like 6-Bromo-2-Methyl-4-Azabenzimidazole play a crucial role by sparing teams from having to troubleshoot obscure side-products or reinvest in failed syntheses. Every researcher deserves a fair shot at success, and high-quality intermediates help level the playing field, bringing resource-strapped teams closer to major breakthroughs.
Every time I browse chemical catalogs, I come across a score of benzimidazole variants. It’s easy to believe one can swap in any similar-looking precursor and get the same result. Experience teaches otherwise. Lacking the bromo position at 6 or that key methyl at 2 changes not only reactivity but downstream properties like solubility and metabolic profile. Colleagues have tested close analogs, only to hit roadblocks in late-stage functionalization or see wild shifts in biological results. 6-Bromo-2-Methyl-4-Azabenzimidazole fills a sweet spot, combining practical reactivity with the structural finesse necessary for demanding SAR campaigns.
My years in interdisciplinary teams taught that no success happens in a vacuum. Sharing real-world experience—how a compound performs, what to expect, what to avoid—elevates all research efforts. Within focus groups and online scientific forums, I’ve seen questions answered, warnings exchanged, and ideas sparked simply over a discussion of the right intermediate. The growth in public protocols for 6-Bromo-2-Methyl-4-Azabenzimidazole reflects its rising value in the community. Each new insight contributes to better project outcomes, reducing wasted time and resources for everyone.
Chemistry education rests not just on theory but on translating that knowledge into practice. Students and young researchers, given the chance, learn immeasurably from working with robust, well-characterized compounds. I’ve supervised dozens of thesis projects that depended on reliable access to specialty intermediates. 6-Bromo-2-Methyl-4-Azabenzimidazole lends itself well to methodology training, teaching hands-on skills in cross-coupling, functional group manipulation, and purification techniques. These lessons, gained early, build the scientific intuition needed for rising careers in industry or academia.
Being able to reproduce the key steps of a published synthesis serves as a measure of credibility and scientific progress. I’ve encountered a fair share of published methods that work only thanks to the quirks of a particular reagent batch. Products such as 6-Bromo-2-Methyl-4-Azabenzimidazole, supplied with detailed characterization and performance history, let researchers publish with confidence. Wider adoption and sharing of reliable intermediates foster open science and greater trust between teams, reviewers, and the broader research community.
Universities and early-stage companies often push the envelope, taking risks and experimenting with new reaction types or biological targets. Success or failure often hinges on the handful of intermediates at the chemist’s disposal. 6-Bromo-2-Methyl-4-Azabenzimidazole’s robust reactivity and flexible core make it a powerful springboard for invention. I’ve known start-ups that moved fast by leveraging such specialty compounds, pivoting from target validation to lead optimization—and even to clinical candidate selection—with fewer detours and dead ends.
Years of procurement experience have taught me that price isn’t everything—clear documentation, reliable shipping, and responsive customer support keep research running smoothly. Across multiple institutions, I’ve seen the headaches caused by mislabeled or poorly certified reagents. Reputable suppliers of 6-Bromo-2-Methyl-4-Azabenzimidazole earn repeat buyers by sticking to transparent quality controls, batch certificates, and open communication. This transparency fosters long-term relationships and sets a higher bar for the whole industry.
As precision medicine takes root, chemists reach ever deeper into the periodic table and functional group toolbox to deliver molecules for specific patient groups. Intermediates like 6-Bromo-2-Methyl-4-Azabenzimidazole make it feasible to custom-build molecules tailored to unique genetic or disease characteristics. Collaborating with project teams focused on oncology or infectious disease, I’ve seen how this flexibility enables the design of next-generation molecules that approach once-untreatable conditions. Having trusted starting points clears a path for clinical innovation and better patient outcomes.
Long hours in academic and industrial labs have shown me just how fragile research can be. Unexpected bottlenecks—be it a supply glitch, regulatory delay, or failed synthesis—can grind progress to a halt. Sourcing 6-Bromo-2-Methyl-4-Azabenzimidazole from suppliers invested in rigorous logistics and documentation adds an extra measure of resilience to projects. Labs better equipped to manage interruptions can weather setbacks, stay competitive, and deliver results for their stakeholders.
Every research decade brings new questions, targets, and technologies. Specialty intermediates such as 6-Bromo-2-Methyl-4-Azabenzimidazole remain central as science evolves. I expect demand to grow as synthetic and medicinal chemists pursue bolder, more complex goals. Review boards and funding agencies want to see evidence of creative risk-taking, and compounds that simplify synthetic complexity will retain their appeal. The future lies with teams ready to adapt, using every advantage—including the right intermediates—to spark the next discovery.
Looking back on years spent at the bench, gratitude follows toward compounds that genuinely make a difference. 6-Bromo-2-Methyl-4-Azabenzimidazole stands as a testament to ongoing innovation in supporting lab work at every scale. It’s more than just another intermediate—it represents practical progress, smoother workflows, and the promise of discovery ready to unfold in the hands of scientists who trust the building blocks they choose.
